Amundi Has $131.77 Million Stake in Mettler-Toledo International, Inc. $MTD

Key Points

• Amundi increased its stake in Mettler-Toledo International, owning approximately 0.58% of the company, worth $131.77 million after acquiring additional shares in the first quarter.
• Mettler-Toledo stock has seen recent price adjustments from analysts, with Citigroup setting a new target price of $1,600 and the average target price now at $1,311.11.
• Recent insider trading activity included sales by CFO Shawn Vadala and Director Thomas P. Salice, reflecting a notable 5.56% and 78.96% decrease in their respective positions.

Amundi increased its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 6.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 120,309 shares of the medical instruments supplier's stock after purchasing an additional 6,876 shares during the quarter. Amundi owned approximately 0.58% of Mettler-Toledo International worth $131,767,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC lifted its stake in Mettler-Toledo International by 39.1% in the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after acquiring an additional 25 shares during the last quarter. QRG Capital Management Inc. lifted its stake in Mettler-Toledo International by 29.4% in the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock valued at $577,000 after acquiring an additional 111 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Mettler-Toledo International by 13.3% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock valued at $2,929,000 after acquiring an additional 292 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in Mettler-Toledo International by 95.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock valued at $2,600,000 after acquiring an additional 1,073 shares during the last quarter. Finally, Boston Trust Walden Corp lifted its stake in Mettler-Toledo International by 7.1% in the first quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock valued at $40,871,000 after acquiring an additional 2,296 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the firm's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the transaction, the chief financial officer directly owned 5,095 shares of the company's stock, valued at $6,389,588.55. This trade represents a 5.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the firm's stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the transaction, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock valued at $2,371,208 in the last ninety days. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Stock Up 1.3%

MTD stock opened at $1,304.65 on Friday. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,521.01. The firm has a market cap of $26.88 billion, a P/E ratio of 33.04, a P/E/G ratio of 3.86 and a beta of 1.37. The company's 50-day moving average price is $1,251.17 and its two-hundred day moving average price is $1,186.88.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same period last year, the firm earned $9.65 EPS. The business's quarterly revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have commented on MTD shares. Evercore ISI cut their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research note on Monday, August 4th. Bank of America increased their price target on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Citigroup raised their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Thursday, August 21st. Barclays started coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 target price for the company. Finally, UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their target price for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $1,311.11.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.